THOMAS PHD ADAMS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for THOMAS PHD ADAMS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of THOMAS PHD ADAMS. THOMAS PHD ADAMS is a Director in LA JOLLA PHARMACEUTICAL CO ($LJPC) and an Chief Executive Officer in Trovagene, Inc. ($XNOM.OB) and a Director in Trovagene, Inc. ($XNOM.OB) and a Director in SYNERGY PHARMACEUTICALS, INC. ($SGYP) and a Director in Hepion Pharmaceuticals, Inc. ($CTRV).
Address: 6455 NANCY RIDGE DRIVE SAN DIEGO 92121 CA
Companies in which THOMAS PHD ADAMS is an Insider
Cardiff Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of THOMAS PHD ADAMS: Chief Executive Officer, Director
Holdings: 351,959 shares
Latest Transaction: Jun 24 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Hepion Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of THOMAS PHD ADAMS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 21 2020
$HEPA Market Capitalization: $85.72M
$HEPA Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LA JOLLA PHARMACEUTICAL CO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of THOMAS PHD ADAMS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 23 2008
$LJPC Market Capitalization: $355.22M
$LJPC Previous Close: $19.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNERGY PHARMACEUTICALS LLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of THOMAS PHD ADAMS: Director
Holdings: 100,023 shares
Current Value: $612,141
Latest Transaction: Jul 06 2018
$SGYP Market Capitalization: $1.11B
$SGYP Previous Close: $6.12
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of THOMAS PHD ADAMS
Sentiment: All, XNOM.OB, HEPA, LJPC, SGYP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | ADAMS THOMAS PHD | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 91,050 | |
| Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | ADAMS THOMAS PHD | Director | Option Exercise | A | 1.63 | 60,000 | 97,800 | 61,051 | |
| Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | ADAMS THOMAS PHD | Director | Option Exercise | A | 3.24 | 970 | 3,143 | 1,051 | |
| Jun 24 2019 | XNOM.OB | Trovagene, Inc. | ADAMS THOMAS PHD | Chief Executive Off ... | Option Exercise | A | 2.48 | 298,230 | 739,610 | 304,725 | |
| Jul 06 2018 | SGYP | SYNERGY PHARMACEUT ... | ADAMS THOMAS PHD | Director | Option Exercise | M | 0.50 | 100,023 | 50,012 | 434,223 | |
| Jul 06 2018 | SGYP | SYNERGY PHARMACEUT ... | ADAMS THOMAS PHD | Director | Payment of Exercise | F | 0.00 | 27,785 | 0 | 72,238 | 100 K to 72.2 K (-27.78 %) |
| Jul 06 2018 | SGYP | SYNERGY PHARMACEUT ... | ADAMS THOMAS PHD | Director | Buy | M | 0.50 | 100,023 | 50,012 | 100,023 | 0 to 100 K |